<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> was produced by bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> in female Sprague-Dawley rats </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="10" ids="8776">Ranitidine</z:chebi>, a <z:chebi fb="11" ids="18295">histamine</z:chebi> H2 receptor blocking agent, given intraperitoneally 30 min prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, exerted a dose-dependent protective effect on water accumulation and ion shifts in the brain (<z:chebi fb="1" ids="29101">Na+</z:chebi>, K+ and <z:chebi fb="0" ids="29108">Ca2+</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>To decide whether <z:chebi fb="10" ids="8776">ranitidine</z:chebi> can prevent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0002181'>brain edema</z:hpo> when given in the postischemic period, <z:chebi fb="10" ids="8776">ranitidine</z:chebi> (10 mg/kg i.p.) was administered 1, 2, and 3 h respectively after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Early (1 h) postocclusion treatment was still able to attenuate the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced water accumulation and maldistribution of ions in the brain tissue </plain></SENT>
</text></document>